Clinical Trial Update: Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL) [Phase 3]

View source ↗

Summary

Phase 3 pediatric dosing study (PEARL) evaluated the appropriate ritonavir-boosted lopinavir dose in Thai HIV-infected children; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV-infected Children | Phase 3 | Status: COMPLETED